Wechsler Daniel Mark 4
4 · MELINTA THERAPEUTICS, INC. /NEW/ · Filed Nov 7, 2017
Insider Transaction Report
Form 4
Wechsler Daniel Mark
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2017-11-03+550,981→ 550,981 totalExercise: $11.63Exp: 2027-11-03→ Common Stock (550,981 underlying) - Award
Restricted Stock Units
2017-11-03+183,661→ 183,661 totalExercise: $0.00→ Common Stock (183,661 underlying)
Footnotes (1)
- [F1]The award vests 25% on November 3, 2018 and the remainder will vest in equal monthly installments during the 3 years following the initial vesting date, subject to the Reporting Person's continued employment with the Issuer.